Evidence map›Paper›PMID 26581239›Full record

ArticleJournal of immunology research2015

Automated Evaluation of Crithidia luciliae Based Indirect Immunofluorescence Tests: A Novel Application of the EUROPattern-Suite Technology.

Stefan Gerlach, Kai Affeldt, Lena Pototzki, Christopher Krause, Jörn Voigt, Johanna Fraune, Kai Fechner

Open access · goldAbstract read
In one paragraph

Article in Journal of immunology research, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
2.1field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 11 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Stefan GerlachInstitute for Experimental Immunology, EUROIMMUN, Seekamp 31, 23560 Lübeck, Germany.
Kai AffeldtInstitute for Experimental Immunology, EUROIMMUN, Seekamp 31, 23560 Lübeck, Germany.
Lena PototzkiInstitute for Experimental Immunology, EUROIMMUN, Seekamp 31, 23560 Lübeck, Germany.
Christopher KrauseInstitute for Experimental Immunology, EUROIMMUN, Seekamp 31, 23560 Lübeck, Germany.
Jörn VoigtInstitute for Experimental Immunology, EUROIMMUN, Seekamp 31, 23560 Lübeck, Germany.
Johanna FrauneInstitute for Experimental Immunology, EUROIMMUN, Seekamp 31, 23560 Lübeck, Germany.
Kai FechnerInstitute for Experimental Immunology, EUROIMMUN, Seekamp 31, 23560 Lübeck, Germany.
Euroimmun Medizinische Labordiagnostika (Germany) · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Systemic lupus erythematosus (SLE) is a severe rheumatic autoimmune disease with various clinical manifestations. Anti-dsDNA antibodies are an important immunological hallmark of SLE and their occurrence represents a major criterion for the diagnosis. Among the commonly applied test systems for determination of anti-dsDNA antibodies, the indirect immunofluorescence test (IIFT) using the flagellated kinetoplastida Crithidia luciliae is considered to be highly disease specific at moderate sensitivity. Since IIFT, however, is claimed to be affected by subjective interpretation and a lack of standardization, there has been an increasing demand for automated pattern interpretation of immunofluorescence reactions in recent years. Corresponding platforms are already available for evaluation of anti-nuclear antibody (ANA) IIFT on HEp-2 cells, the recommended "gold standard" for ANA screening in the diagnosis of various systemic rheumatic autoimmune diseases. For one of these systems, the "EUROPattern-Suite" computer-aided immunofluorescence microscopy (CAIFM), automated interpretation of microscopic fluorescence patterns was extended to the Crithidia luciliae based anti-dsDNA IIFT.

Indexed as

Fluorescent Antibody Technique, IndirectAntibodies, AntinuclearAutomation, LaboratoryCrithidiaHumansLupus Erythematosus, SystemicMicroscopy, FluorescenceReproducibility of ResultsRheumatic DiseasesSensitivity and SpecificityWorkflowAntibodies, Antinuclear

Identifiers

PMID26581239
PMCPMC4637128
OpenAlexW2113297014

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.